VANTAGE

News

· Conference

VANTAGE at ESMO Congress 2026

The VANTAGE team took part in the ESMO Congress 2026 in Madrid (23–27 October), one of the largest oncology conferences in the world. We presented an e-poster showing how human-based tumor-on-chip models can support the preclinical testing of antibody–drug conjugates.

· Event

VANTAGE kicks off with the EIC portfolio in Brussels

VANTAGE was officially launched at the kick-off meeting of the European Innovation Council (EIC) Advanced Innovation Challenge on New Approach Methodologies in Brussels. The team presented the project’s goals to the EIC programme team and met the other projects selected under the same challenge.